Leukemia patients who enroll in LLS's PedAL screening trial and are found to have certain alterations will be directed to receive ziftomenib in a Phase I study.

It's no secret that our waistlines often expand in middle-age, but the problem isn't strictly cosmetic. Belly fat accelerates aging and slows down metabolism, increasing our risk for developing ...

It's no secret that our waistlines often expand in middle age, but the problem isn't strictly cosmetic. Belly fat accelerates ...

Innovative imaging with Phenocycler 2.0 enables detailed study of mouse bone marrow, paving the way for improved therapies for autoimmune diseases and leukemia.

GEO-CM04S1 Demonstrates Durable T Cell and Antibody Responses in Healthy and Immunocompromised Populations ...

The risk of cancer goes up with age, in part because aging impedes the body's ability to detect and destroy cells with ...

In 2021, research led by Ryan Flynn, MD, PhD, and his mentor, Nobel laureate Carolyn Bertozzi, PhD, opened a new chapter in biology, characterizing a new kind of player on the cell surface: glycoRNAs.

Researchers show that glycoRNAs, uncovered by the lab of Nobel Laureate, Carolyn Bertozzi, can be used to fight cancer.

Fred Hutch and MSK researchers showed that tumors driven by hiccups in RNA processing can't hid from the immune system. In ...

Researchers sought to determine whether MSD HSCT or auto-HSCT would have advantages over chemotherapy in post-remission treatment for patients with AML.

Now, Kaufman, a 20-year-old sophomore baseball player and business finance major at Roanoke College, is facing his toughest ...